Jessica Zhu

Medicine · Health Sciences

17h-index2.5kcitations32works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pregnancy-related medical research(5), Renal Diseases and Glomerulopathies(4), Systemic Lupus Erythematosus Research(3), Atherosclerosis and Cardiovascular Diseases(3), Regulation of Appetite and Obesity(2)

Publications32 total

Systemic therapy in upper tract urothelial carcinoma
2024
Targeting, Personalization, and Engagement in an Agricultural Advisory Service
AEA Randomized Controlled Trials·2024
Abstract C136: VHL, PBRM1, and BAP1 mutation variants and response to first-line therapies in patients with metastatic clear-cell renal cell carcinoma (mRCC)
Molecular Cancer Therapeutics·2023
Current therapies and future prospective for locally aggressive mesenchymal tumors
Frontiers in Oncology·2023· 3 citedOpen Access
BPI23-013: Comparison of Modified Patient-Reported Paper G8 and EPIC G4 + 4 With Clinician-Reported Standard G8 to Screen Frailty in Elderly Patients With Cancer
Journal of the National Comprehensive Cancer Network·2023
Leveraging Data, Models & Farming Innovation to Prevent, Prepare for & Manage Pest Incursions: Delivering a Pest Risk Service for Low-Income Countries
2023Open Access
Evaluating the Impact of a Digital Agriculture Advisory Program in India
AEA Randomized Controlled Trials·2021
Teaching Students About Conversational AI Using Convo, a Conversational Programming Agent
2021· 25 cited
Examination of Food Insecurity, Socio-Demographic, Psychosocial, and Physical Factors among Residents in Public Housing
Ethnicity & Disease·2021· 6 citedOpen Access
Triple negative breast cancer development can be selectively suppressed by sustaining an elevated level of cellular cyclic AMP through simultaneously blocking its efflux and decomposition
Oncotarget·2016· 29 citedOpen Access
3,5-Dihydroxybenzoic Acid, a Specific Agonist for Hydroxycarboxylic Acid 1, Inhibits Lipolysis in Adipocytes
Journal of Pharmacology and Experimental Therapeutics·2012· 118 cited
Study of GPR81, the Lactate Receptor, from Distant Species Identifies Residues and Motifs Critical for GPR81 Functions
Molecular Pharmacology·2011· 71 cited
Mutagenesis studies of neuropeptide S identify a suitable peptide tracer for neuropeptide S receptor binding studies and peptides selectively activating the I107 variant of human neuropeptide S receptor
European Journal of Pharmacology·2010· 8 cited
Reply to Xu: Role of Lactate in Lipid Metabolism, Just Always Inhibiting Lipolysis?
Journal of Biological Chemistry·2009Open Access
Probing the Functional Domains of Relaxin‐3 and the Creation of a Selective Antagonist for RXFP3/GPCR135 over Relaxin Receptor RXFP1/LGR7
Annals of the New York Academy of Sciences·2009· 9 cited
Lactate Inhibits Lipolysis in Fat Cells through Activation of an Orphan G-protein-coupled Receptor, GPR81
Journal of Biological Chemistry·2008· 570 citedOpen Access
Identification of the domains in RXFP4 (GPCR142) responsible for the high affinity binding and agonistic activity of INSL5 at RXFP4 compared to RXFP3 (GPCR135)
European Journal of Pharmacology·2008· 22 cited
Laser-Microdissection-Based Transcriptomics Using Microarrays
Drug discovery series·2007
Laser-Microdissection-Based Transcriptomics Using Microarrays
2007
R3(BΔ23–27)R/I5 Chimeric Peptide, a Selective Antagonist for GPCR135 and GPCR142 over Relaxin Receptor LGR7
Journal of Biological Chemistry·2007· 137 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Changlu Liu(12), Timothy W. Lovenberg(11), Chester Kuei(9), Jingxue Yu(9), Fredrik Kamme(9), Steven W. Sutton(8), Jiejun Wu(7), Pascal Bonaventure(6), Jonathan Shelton(5), Da‐Thao Tran(5), Mark G. Erlander(5), Diane Nepomuceno(5), Taraneh Mirzadegan(4), Nancy Miller(4), Michael R. Jackson(4), Lin Luo(3), Karin S. Peterson(3), Jing-Feng Huang(3), Robert Winchester(3), Ross A. D. Bathgate(3)